- 1、本文档共36页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
糖尿病心血管疾病的非降脂治疗与临床评价ppt课件_1
Clinical Evaluation and Nonlipid Treatment of Coronary Artery Disease in the Diabetic PatientRichard Nesto, MD Prevalence of Asymptomatic CAD in Diabetes Mellitus Indications for Cardiac Testing in Diabetic Patients Factors Limiting Accuracy of Noninvasive Stress Tests for CAD Benefits of Early Detection of CAD Blood Pressure and CVD: Framingham Heart Study Effect of Glycemic Control in the UK Prospective Diabetes Study (UKPDS) Reasons for Death in UKPDS Intensive Treatment Arm: 10-Year Follow-up Effect of Blood Pressure Control in the UKPDSTight vs. Less Tight Control UKPDS: ACE Inhibitor vs. Beta-blocker for HTNAggregate Clinical Endpoints Systolic Hypertension in Europe (Syst-Eur) Trial: Effect of Systolic BP Control on All Cardiovascular Events at 2 Years Major Outcomes of the Hypertension Optimal Treatment (HOT) Trial: Diabetes Subgroup HOT Trial:Cardiovascular Events in Diabetics and Nondiabetics—Effect of Diastolic Target at 4 Years Completed Clinical Trials with Antihypertensive Agents in Diabetes Heart Outcomes Prevention Evaluation (HOPE) StudyEffect of Ramipril on Cardiovascular Events (Myocardial Infarction, Stroke, or CVD Death) ~ 4.5 Yrs Diabetes Increases Risk of Coronary PlaqueDisruption and Thrombosis Cause of Myocardial Infarction Impact of Serum Fibrinogen and Total Cholesterol Levels on Risk of Coronary Events in ECAT Effect of Aspirin on Mortality in Type 2 Patients with CHD: Bezafibrate Infarction Prevention Study Antiplatelet Agents Reduce CVD Events in Patients with Diabetes: Antiplatelet Trialists’ Collaboration Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI): Benefit of Tight Glycemic Control in No Insulin – Low Risk Cohort Effect of Trandolapril on Post-MI CHF Progression: Trandolapril Cardiac Evaluation (TRACE) Effect of Trandolapril on Secondary Endpoints in TRACE Effect of Diabetes on 30-Day Mortality: Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Co
文档评论(0)